Trial intelligence / Profile preview

Voluven versus Ringer for hemodynamic changes after spinal anesthesia in lower limb orthopedic surgery

IRCT20190210042670N1Phase 3Completed

Sponsor
Zahedan University of Medical Sciences
Start
Dec 2018
Modality
Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 3, open-label trial of Volulyte and lactated ringer's solution in Cardiovascular collapse (2 arms), sponsored by Zahedan University of Medical Sciences. Primary endpoints: Heart rate, Blood pressure and 2 more. Started Dec 2018; status: completed.

02

Drugs

Volulytelactated ringer's solution
03

Conditions

Cardiovascular collapse

Beyond the preview

Go deeper on IRCT20190210042670N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190210042670N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call